In this study, we found that NT-proBNP concentration assessment strongly predicted first-onset heart failure and augmented coronary heart disease and stroke prediction, suggesting that NT-proBNP concentration assessment could serve as a multipurpose biomarker in new approaches that integrate heart failure into cardiovascular disease primary prevention. This evidence concerns the gene NPPB and coronary artery disorder.